135 related articles for article (PubMed ID: 9222352)
41. Inability of bm14 mice to respond to Theiler's murine encephalomyelitis virus is caused by defective antigen presentation, not repertoire selection.
Block MS; Mendez-Fernandez YV; Van Keulen VP; Hansen MJ; Allen KS; Taboas AL; Rodriguez M; Pease LR
J Immunol; 2005 Mar; 174(5):2756-62. PubMed ID: 15728484
[TBL] [Abstract][Full Text] [Related]
42. Prostaglandin E2 produced following infection with Theiler's virus promotes the pathogenesis of demyelinating disease.
Kim SJ; Jin YH; Kim BS
PLoS One; 2017; 12(4):e0176406. PubMed ID: 28445497
[TBL] [Abstract][Full Text] [Related]
43. Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide.
Mendez-Fernandez YV; Johnson AJ; Rodriguez M; Pease LR
Eur J Immunol; 2003 Sep; 33(9):2501-10. PubMed ID: 12938226
[TBL] [Abstract][Full Text] [Related]
44. Central nervous system cytokine mRNA expression following Theiler's murine encephalomyelitis virus infection.
Sato S; Reiner SL; Jensen MA; Roos RP
J Neuroimmunol; 1997 Jun; 76(1-2):213-23. PubMed ID: 9184653
[TBL] [Abstract][Full Text] [Related]
45. FVB mice transgenic for the H-2Db gene become resistant to persistent infection by Theiler's virus.
Azoulay A; Brahic M; Bureau JF
J Virol; 1994 Jun; 68(6):4049-52. PubMed ID: 8189541
[TBL] [Abstract][Full Text] [Related]
46. Characterization of Theiler's murine encephalomyelitis virus (TMEV)-specific delayed-type hypersensitivity responses in TMEV-induced demyelinating disease: correlation with clinical signs.
Clatch RJ; Lipton HL; Miller SD
J Immunol; 1986 Feb; 136(3):920-7. PubMed ID: 2416841
[TBL] [Abstract][Full Text] [Related]
47. Multiple pathways to induction of virus-induced autoimmune demyelination: lessons from Theiler's virus infection.
Miller SD; Olson JK; Croxford JL
J Autoimmun; 2001 May; 16(3):219-27. PubMed ID: 11334486
[TBL] [Abstract][Full Text] [Related]
48. Spontaneous CNS remyelination in beta 2 microglobulin-deficient mice following virus-induced demyelination.
Miller DJ; Rivera-Quiñones C; Njenga MK; Leibowitz J; Rodriguez M
J Neurosci; 1995 Dec; 15(12):8345-52. PubMed ID: 8613767
[TBL] [Abstract][Full Text] [Related]
49. CD8(+) T cells from Theiler's virus-resistant BALB/cByJ mice downregulate pathogenic virus-specific CD4(+) T cells.
Haynes LM; Vanderlugt CL; Dal Canto MC; Melvold RW; Miller SD
J Neuroimmunol; 2000 Jul; 106(1-2):43-52. PubMed ID: 10814781
[TBL] [Abstract][Full Text] [Related]
50. Differential generation of class I H-2D- versus H-2K-restricted cytotoxicity against a demyelinating virus following central nervous system infection.
Lin X; Pease LR; Rodriguez M
Eur J Immunol; 1997 Apr; 27(4):963-70. PubMed ID: 9130651
[TBL] [Abstract][Full Text] [Related]
51. Treatment with bacterial LPS renders genetically resistant C57BL/6 mice susceptible to Theiler's virus-induced demyelinating disease.
Pullen LC; Park SH; Miller SD; Dal Canto MC; Kim BS
J Immunol; 1995 Nov; 155(9):4497-503. PubMed ID: 7594613
[TBL] [Abstract][Full Text] [Related]
52. The role of cellular immune response in Theiler's virus-induced central nervous system demyelination.
Njenga MK; Marques C; Rodriguez M
J Neuroimmunol; 2004 Feb; 147(1-2):73-7. PubMed ID: 14741431
[TBL] [Abstract][Full Text] [Related]
53. Differential expression of H-2K and H-2D in the central nervous system of mice infected with Theiler's virus.
Altintas A; Cai Z; Pease LR; Rodriguez M
J Immunol; 1993 Sep; 151(5):2803-12. PubMed ID: 8360494
[TBL] [Abstract][Full Text] [Related]
54. Investigation of the role of delayed-type-hypersensitivity responses to myelin in the pathogenesis of Theiler's virus-induced demyelinating disease.
Borrow P; Welsh CJ; Tonks P; Dean D; Blakemore WF; Nash AA
Immunology; 1998 Apr; 93(4):478-84. PubMed ID: 9659218
[TBL] [Abstract][Full Text] [Related]
55. Differential expression of TGF-beta, IL-2, and other cytokines in the CNS of Theiler's murine encephalomyelitis virus-infected susceptible and resistant strains of mice.
Chang JR; Zaczynska E; Katsetos CD; Platsoucas CD; Oleszak EL
Virology; 2000 Dec; 278(2):346-60. PubMed ID: 11118358
[TBL] [Abstract][Full Text] [Related]
56. Chromosome 14 contains determinants that regulate susceptibility to Theiler's virus-induced demyelination in the mouse.
Bureau JF; Drescher KM; Pease LR; Vikoren T; Delcroix M; Zoecklein L; Brahic M; Rodriguez M
Genetics; 1998 Apr; 148(4):1941-9. PubMed ID: 9560407
[TBL] [Abstract][Full Text] [Related]
57. Roles of the H-2D(b) and H-K(b) genes in resistance to persistent Theiler's murine encephalomyelitis virus infection of the central nervous system.
Azoulay-Cayla A; Syan S; Brahic M; Bureau JF
J Gen Virol; 2001 May; 82(Pt 5):1043-1047. PubMed ID: 11297678
[TBL] [Abstract][Full Text] [Related]
58. The Theiler's murine encephalomyelitis virus (TMEV) model for multiple sclerosis shows a strong influence of the murine equivalents of HLA-A, B, and C.
Clatch RJ; Melvold RW; Dal Canto MC; Miller SD; Lipton HL
J Neuroimmunol; 1987 Jun; 15(2):121-35. PubMed ID: 3584435
[TBL] [Abstract][Full Text] [Related]
59. Bone marrow chimeras reveal non-H-2 hematopoietic control of susceptibility to Theiler's virus persistent infection.
Aubagnac S; Brahic M; Bureau JF
J Virol; 2002 Jun; 76(11):5807-12. PubMed ID: 11992010
[TBL] [Abstract][Full Text] [Related]
60. HLA-DQ polymorphism influences progression of demyelination and neurologic deficits in a viral model of multiple sclerosis.
Pavelko KD; Drescher KM; McGavern DB; David CS; Rodriguez M
Mol Cell Neurosci; 2000 Jun; 15(6):495-509. PubMed ID: 10860577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
